I don't think I can give advice on what the system for surveillance should be. I think it's something that benefits, as I said, from scale efficiencies. Rather than having each province have special laboratory capacity for antimicrobial resistance, there's probably a division of labour and reference laboratories that would be a much more cost-efficient organization of high-cost diagnostics for drug susceptibility testing for antimicrobial resistance.
What would be important in the design of laboratory networks is to think about how you can take advantage of scale efficiencies and modern technology, which is instantaneous in the digital age, and avoid creating expensive infrastructures that will be difficult to sustain in the long run and not necessarily the best use of public resources.